NewGenIvf (NIVFW) Operating Expenses (2024 - 2025)

NewGenIvf (NIVFW) posted quarterly Operating Expenses of $6.8 million for Q4 2025, up 56.47% YoY from $4.3 million in Q4 2024, and up 358.55% sequentially from -$2.6 million in Q3 2025.

NewGenIvf (NIVFW) Operating Expenses (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Operating Expenses across 2 years of filings, most recently posting $6.8 million for Q4 2025.

  • In Q4 2025, Operating Expenses rose 56.47% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $8.5 million (up 117.61% YoY), while the FY2025 annual figure was $616423.0, down 79.37% from the prior year.
  • Operating Expenses climbed to $6.8 million in Q4 2025, from -$2.6 million in the prior quarter.
  • Over the last five years, Operating Expenses for NIVFW reached as high as $6.8 million in Q4 2025 and fell as low as -$2.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn 16.82 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 572.94 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 27.00 Mn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn 2.93 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 1.29 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 1.26 Bn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 3.99 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 1.30 Bn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn -25.79 Mn
10 NewGenIvf - - 524,025.00 6.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.80 Mn
Sep 30, 2025 -2.63 Mn
Dec 31, 2024 4.35 Mn
Sep 30, 2024 -432,516.00